These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27268446)

  • 1. [HPV vaccination].
    Stronski Huwiler S; Spaar A
    Ther Umsch; 2016; 73(5):241-6. PubMed ID: 27268446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of human papillomavirus vaccination.
    Brotherton JM; Ogilvie GS
    Curr Opin Oncol; 2015 Sep; 27(5):399-404. PubMed ID: 26258273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccine.
    Luxembourg A; Bautista O; Moeller E; Ritter M; Chen J
    Contemp Clin Trials; 2015 May; 42():18-25. PubMed ID: 25749310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
    Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
    Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.
    Obstet Gynecol; 2015 Sep; 126(3):693. PubMed ID: 26287785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development.
    Fruscalzo A; Londero AP; Bertozzi S; Lellè RJ
    Minerva Med; 2016 Feb; 107(1):26-38. PubMed ID: 26473283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.
    Ahn J; Peng S; Hung CF; Roden RBS; Best SR
    Laryngoscope; 2018 Jan; 128(1):E16-E20. PubMed ID: 28868617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
    Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
    BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV9: Combating HPV-associated cancers by strengthening serotype defenses.
    Dougherty SA; Hayney MS
    J Am Pharm Assoc (2003); 2015; 55(6):670-672. PubMed ID: 26547601
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
    Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
    Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV vaccination of immunocompromised hosts.
    Garland SM; Brotherton JML; Moscicki AB; Kaufmann AM; Stanley M; Bhatla N; Sankaranarayanan R; de Sanjosé S; Palefsky JM;
    Papillomavirus Res; 2017 Dec; 4():35-38. PubMed ID: 29179867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for the HPV vaccine in adolescents: a review of the literature.
    Soares GR; Vieira Rda R; Pellizzer EP; Miyahara GI
    J Infect Public Health; 2015; 8(2):105-16. PubMed ID: 25453595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic human papillomavirus vaccines: past, present and future.
    Anderson LA
    Pathology; 2012 Jan; 44(1):1-6. PubMed ID: 22157686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine update.
    Gilmer LS
    Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of HPV vaccination in Belize.
    Walwyn L; Janusz CB; Clark AD; Prieto E; Waight E; Largaespada N
    Vaccine; 2015 May; 33 Suppl 1():A174-81. PubMed ID: 25919158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women.
    Perez G; Lazcano-Ponce E; Hernandez-Avila M; García PJ; Muñoz N; Villa LL; Bryan J; Taddeo FJ; Lu S; Esser MT; Vuocolo S; Sattler C; Barr E
    Int J Cancer; 2008 Mar; 122(6):1311-8. PubMed ID: 18000825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human papillomavirus (HPV) vaccination in males : evidence and practice].
    Perrin A; Iselin C
    Rev Med Suisse; 2019 Nov; 15(673):2202-2204. PubMed ID: 31778050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.